GIE Medical has launched two large, multicenter randomized controlled clinical trials in the United States to investigate ProTractX3™ TTS DCB.
GIE Medical Launches Two Clinical Trials to Investigate Use of a Multi-Stage Drug Coated Balloon in Esophageal and Bowel Strictures
December 13, 2022 10:00 ET | GIE Medical
Plymouth, MN, Dec. 13, 2022 (GLOBE NEWSWIRE) -- GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, has launched two...